GSK Cervarix Setback: FDA Questions On HPV Vaccine Bode Well For Merck
Executive Summary
The launch of GlaxoSmithKline human papilloma virus vaccine Cervarix will be further delayed behind Merck's competing Gardasil vaccine after FDA issued a "complete response" letter related to the BLA Dec. 17